A regulatory viewpoint on transporter-based drug interactions

Author： Zhang L.   Zhang Y.   Strong J. M.   Reynolds K. S.   Huang S. -M.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.38, Iss.7-8, 2008-07, pp. : 709-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of cytochrome P450-mediated drug–drug interactions based on the strategies recommended by regulatory authorities

By Kosugi Yohei   Hirabayashi Hideki   Igari Tomoko   Fujioka Yasushi   Hara Yoko   Okuda Teruaki   Moriwaki Toshiya  

Xenobiotica, Vol. 42, Iss. 2, 2012-02 ,pp. : 127-138

Informa Healthcare

Access to resources Recommend Favorite

Prodrug based optimal drug delivery via membrane transporter/receptor

By Yang C.   Tirucherai G.S.   Mitra A.K.  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 2, 2001-03 ,pp. : 159-175

Informa Healthcare

Access to resources Recommend Favorite

The Carnitine Transporter Network: Interactions with Drugs

By Indiveri Cesare   Pochini Lorena   Oppedisano Francesca   Tonazzi Annamaria  

Current Opinion in Chemical Biology, Vol. 4, Iss. 2, 2010-05 ,pp. : 108-123

Elsevier

Access to resources Recommend Favorite

The Carnitine Transporter Network: Interactions with Drugs

By  

Current Chemical Biology, Vol. 4, Iss. 2, 2010-05 ,pp. : 108-123

Bentham Science Publishers

Access to resources Recommend Favorite

Predicting Drug-Target Interactions Based on Small Positive Samples

By  

Current Protein and Peptide Science, Vol. 19, Iss. 5, 2018-03 ,pp. : 479-487

Bentham Science Publishers

Access to resources Recommend Favorite